Halozyme Therapeutics
HALO
#2003
Rank
โ‚น669.10 B
Marketcap
โ‚น5,282
Share price
1.06%
Change (1 day)
62.08%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น140.94 B

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are โ‚น140.94 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น137.31 B-0.74%
2022-12-31โ‚น138.33 B104.55%
2021-12-31โ‚น67.62 B115.97%
2020-12-31โ‚น31.31 B-7.21%
2019-12-31โ‚น33.74 B153.53%
2018-12-31โ‚น13.31 B-33.09%
2017-12-31โ‚น19.89 B-0.42%
2016-12-31โ‚น19.97 B116.64%
2015-12-31โ‚น9.22 B16.93%
2014-12-31โ‚น7.88 B4.79%
2013-12-31โ‚น7.52 B60.05%
2012-12-31โ‚น4.70 B62.04%
2011-12-31โ‚น2.90 B-8.82%
2010-12-31โ‚น3.18 B-2.73%
2009-12-31โ‚น3.27 B7.58%
2008-12-31โ‚น3.04 B68.81%
2007-12-31โ‚น1.80 B76.79%
2006-12-31โ‚น1.01 B883.21%
2005-12-31โ‚น0.10 B66.86%
2004-12-31โ‚น62.11 M398.02%
2003-12-31โ‚น12.47 M-57.37%
2002-12-31โ‚น29.25 M18336.74%
2001-12-31โ‚น0.15 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น56.17 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.885 T 3,366.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.560 T 1,007.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.756 T 7,531.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.104 T 3,521.58%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น9.190 T 6,420.72%๐Ÿ‡บ๐Ÿ‡ธ USA